ZNF541
gene geneOn this page
Also known as DKFZp434I1930
Summary
ZNF541 (zinc finger protein 541, HGNC:25294) is a protein-coding gene on chromosome 19q13.33, encoding Zinc finger protein 541 (Q9H0D2). Transcription regulator which is essential for male fertility and for the completion of meiotic prophase in spermatocytes.
Predicted to enable transcription corepressor activity. Predicted to be involved in male meiotic nuclear division and regulation of DNA-templated transcription. Predicted to be located in nucleus. Predicted to be part of histone deacetylase complex and transcription regulator complex.
Source: NCBI Gene 84215 — RefSeq curated summary.
At a glance
- Gene–disease (curated): male infertility with azoospermia or oligozoospermia due to single gene mutation (Limited, GenCC)
- GWAS associations: 1
- Clinical variants (ClinVar): 11 total
- MANE Select transcript:
NM_001277075
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25294 |
| Approved symbol | ZNF541 |
| Name | zinc finger protein 541 |
| Location | 19q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp434I1930 |
| Ensembl gene | ENSG00000118156 |
| Ensembl biotype | protein_coding |
| OMIM | 619942 |
| Entrez | 84215 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000263351, ENST00000391901, ENST00000487275, ENST00000595558
RefSeq mRNA: 1 — MANE Select: NM_001277075
NM_001277075
CCDS: CCDS46133
Canonical transcript exons
ENST00000391901 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000930221 | 47521479 | 47521654 |
| ENSE00000930223 | 47528950 | 47529038 |
| ENSE00000930224 | 47529577 | 47529652 |
| ENSE00000952994 | 47544126 | 47545980 |
| ENSE00000952995 | 47540893 | 47540951 |
| ENSE00000952998 | 47538142 | 47538439 |
| ENSE00000953000 | 47532128 | 47532270 |
| ENSE00000953001 | 47531642 | 47531745 |
| ENSE00000953002 | 47521854 | 47521994 |
| ENSE00001510044 | 47520690 | 47521377 |
| ENSE00001510048 | 47549245 | 47549485 |
| ENSE00001510049 | 47555550 | 47555954 |
| ENSE00003606546 | 47539705 | 47539878 |
| ENSE00003636333 | 47532909 | 47532972 |
| ENSE00003638438 | 47540176 | 47540335 |
| ENSE00003926683 | 47573083 | 47573148 |
| ENSE00003933466 | 47571896 | 47572042 |
Expression profiles
Bgee: expression breadth ubiquitous, 146 present calls, max score 83.91.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0639 / max 31.5759, expressed in 13 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 181787 | 0.0361 | 11 |
| 181786 | 0.0278 | 4 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 83.91 | gold quality |
| right testis | UBERON:0004534 | 83.77 | gold quality |
| testis | UBERON:0000473 | 82.04 | gold quality |
| sperm | CL:0000019 | 80.97 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.09 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.79 | gold quality |
| adrenal tissue | UBERON:0018303 | 74.11 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 73.97 | gold quality |
| pancreatic ductal cell | CL:0002079 | 72.86 | silver quality |
| adrenal cortex | UBERON:0001235 | 72.50 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 72.18 | gold quality |
| left adrenal gland | UBERON:0001234 | 72.02 | gold quality |
| right adrenal gland | UBERON:0001233 | 71.73 | gold quality |
| adult organism | UBERON:0007023 | 70.29 | gold quality |
| adrenal gland | UBERON:0002369 | 70.21 | gold quality |
| secondary oocyte | CL:0000655 | 69.29 | silver quality |
| kidney epithelium | UBERON:0004819 | 68.67 | gold quality |
| endothelial cell | CL:0000115 | 68.21 | silver quality |
| tibialis anterior | UBERON:0001385 | 67.76 | silver quality |
| left ovary | UBERON:0002119 | 66.86 | gold quality |
| calcaneal tendon | UBERON:0003701 | 66.44 | gold quality |
| deltoid | UBERON:0001476 | 65.10 | silver quality |
| apex of heart | UBERON:0002098 | 63.89 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 63.87 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 63.87 | gold quality |
| ovary | UBERON:0000992 | 63.66 | gold quality |
| tendon | UBERON:0000043 | 63.58 | gold quality |
| right ovary | UBERON:0002118 | 61.88 | gold quality |
| ileal mucosa | UBERON:0000331 | 61.55 | silver quality |
| myocardium | UBERON:0002349 | 60.94 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.74 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): TP63
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | znf541 | ENSDARG00000052188 |
| mus_musculus | Zfp541 | ENSMUSG00000078796 |
| rattus_norvegicus | Zfp541 | ENSRNOG00000021800 |
| drosophila_melanogaster | CG16779 | FBGN0037698 |
| caenorhabditis_elegans | WBGENE00005006 | |
| caenorhabditis_elegans | WBGENE00009224 | |
| caenorhabditis_elegans | WBGENE00010012 | |
| caenorhabditis_elegans | WBGENE00013632 | |
| caenorhabditis_elegans | rcor-1 | WBGENE00022278 |
Paralogs (5): RCOR1 (ENSG00000089902), RCOR3 (ENSG00000117625), TRERF1 (ENSG00000124496), MIDEAS (ENSG00000156030), RCOR2 (ENSG00000167771)
Protein
Protein identifiers
Zinc finger protein 541 — Q9H0D2 (reviewed: Q9H0D2)
All UniProt accessions (3): Q9H0D2, H7BXG6, M0R167
UniProt curated annotations — full annotation on UniProt →
Function. Transcription regulator which is essential for male fertility and for the completion of meiotic prophase in spermatocytes. Regulates progression of the pachytene stage of meiotic prophase by activating the expression of genes involved in meiosis during spermatogenesis. Maintains the repression of pre-pachytene transcriptional programs, including meiotic double-strand breaks (DSB) formation genes in pachytene spermatocytes and suppresses aberrant DSB formation after mid-pachytene, thus ensuring meiosis progression.
Subunit / interactions. Interacts with DNTTIP1. Identified in a complex with KCDT19, HDAC1 and HSPA2. Component of a histone deacetylase complex containing DNTTIP1, ZNF541, HDAC1 and HDAC2. Identified in a complex with HDAC1, HDAC2, DNTTIP1 and KCTD19.
Subcellular location. Nucleus.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H0D2-3 | 3 | yes |
| Q9H0D2-2 | 2 |
RefSeq proteins (1): NP_001264004* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000949 | ELM2_dom | Domain |
| IPR001005 | SANT/Myb | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR017884 | SANT_dom | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR051066 | Trans_reg/Corepressor | Family |
Pfam: PF00096, PF01448, PF13912
UniProt features (30 total): region of interest 8, compositionally biased region 8, zinc finger region 5, sequence variant 4, domain 2, chain 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H0D2-F1 | 45.27 | 0.03 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 45 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOBP_ORGANELLE_FISSION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, GOBP_MEIOTIC_CELL_CYCLE, RAAGNYNNCTTY_UNKNOWN, GOCC_TRANSCRIPTION_REGULATOR_COMPLEX, RNCTGNYNRNCTGNY_UNKNOWN, GOBP_CELL_CYCLE_PROCESS, GOCC_HISTONE_DEACETYLASE_COMPLEX, GOMF_TRANSCRIPTION_COREPRESSOR_ACTIVITY, AR_Q6, GOBP_MALE_MEIOTIC_NUCLEAR_DIVISION, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_TRANSCRIPTION_COREGULATOR_ACTIVITY
GO Biological Process (8): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357), male meiotic nuclear division (GO:0007140), spermatogenesis (GO:0007283), cell differentiation (GO:0030154), negative regulation of DNA-templated transcription (GO:0045892), positive regulation of DNA-templated transcription (GO:0045893), meiotic cell cycle (GO:0051321)
GO Molecular Function (4): transcription corepressor activity (GO:0003714), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (3): histone deacetylase complex (GO:0000118), nucleus (GO:0005634), transcription regulator complex (GO:0005667)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 3 |
| regulation of DNA-templated transcription | 3 |
| male gamete generation | 2 |
| meiotic nuclear division | 2 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription by RNA polymerase II | 1 |
| meiotic cell cycle | 1 |
| developmental process involved in reproduction | 1 |
| cellular developmental process | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| positive regulation of RNA biosynthetic process | 1 |
| cell cycle | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| transcription coregulator activity | 1 |
| negative regulation of DNA-templated transcription | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| nucleoplasm | 1 |
| nuclear protein-containing complex | 1 |
| catalytic complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
380 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF541 | DNTTIP1 | Q9H147 | 711 |
| ZNF541 | RPS6KL1 | Q9Y6S9 | 667 |
| ZNF541 | M0QYG6 | M0QYG6 | 581 |
| ZNF541 | CCDC51 | Q96ER9 | 534 |
| ZNF541 | ARHGAP23 | Q9P227 | 528 |
| ZNF541 | ZNF710 | Q8N1W2 | 512 |
| ZNF541 | SNRPN | P14648 | 504 |
| ZNF541 | POLD1 | P28340 | 491 |
| ZNF541 | IFT140 | Q96RY7 | 438 |
| ZNF541 | ADPRHL1 | Q8NDY3 | 437 |
| ZNF541 | GOLGA6L6 | A8MZA4 | 418 |
| ZNF541 | ADK | P55263 | 404 |
| ZNF541 | ADGRD2 | Q7Z7M1 | 400 |
| ZNF541 | ODF4 | Q2M2E3 | 394 |
| ZNF541 | ADAMTS16 | Q8TE57 | 381 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| AJUBA | ZNF541 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIP6 | ZNF541 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYC | psi-mi:“MI:0914”(association) | 0.350 | |
| ZNF541 | AJUBA | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF541 | TRIP6 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (6): ZNF541 (Two-hybrid), AJUBA (Two-hybrid), ZNF541 (Cross-Linking-MS (XL-MS)), PFN1 (Cross-Linking-MS (XL-MS)), HSP90AA1 (Cross-Linking-MS (XL-MS)), HSP90AB1 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A0U1RRK4, A0A1W2PPE3, A0A1W2PR82, A0A2Z4LIS9, A2VE02, A4D1S0, A5PKC7, A5PL33, A6H7B4, A6NEL2, A6QP24, A6QPM6, A8MTW9, A8MYA2, D3ZAQ5, D4AAA5, E7EW31, O75474, O75638, O89113, O94850, P0C7X2, P14652, P50617, P70339, Q2KIS6, Q3UN58, Q5JPB2, Q5VZ46, Q6GQX2, Q6NZ36, Q6ZSJ8, Q6ZW13, Q76NI1, Q7TNS8, Q80TS7, Q86UU5, Q8IWN7, Q8N6K4, Q8N944
Diamond homologs: A5PJX4, O75376, P25357, Q0GGX2, Q4KKX4, Q4R2Z8, Q55DP9, Q59E36, Q5FWT8, Q60974, Q6NRZ0, Q6P116, Q8C796, Q8CFE3, Q8IZ40, Q8QG78, Q90WN5, Q9H0D2, Q9H4R4, Q9P2K3, Q9UKL0, Q9WU42, Q9WUB5, Q9Y618, Q3U3N0, Q5REE1, Q5UAK0, Q5ZJ40, Q5ZKT9, Q6PGA0, Q6PJG2, Q7T105, Q8BXJ2, Q8N108, Q8N344, Q96PN7, Q3UHF3, Q4R3R9, Q62599, Q7Z3K6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
11 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2603 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:47521374:CACC:C | acceptor_gain | 1.0000 |
| 19:47521376:CC:C | acceptor_gain | 1.0000 |
| 19:47521377:CC:C | acceptor_gain | 1.0000 |
| 19:47521378:C:CA | acceptor_loss | 1.0000 |
| 19:47521378:C:CC | acceptor_gain | 1.0000 |
| 19:47521379:T:G | acceptor_loss | 1.0000 |
| 19:47521478:CCTT:C | donor_gain | 1.0000 |
| 19:47521523:T:TA | donor_gain | 1.0000 |
| 19:47521524:C:A | donor_gain | 1.0000 |
| 19:47531746:C:CC | acceptor_gain | 1.0000 |
| 19:47531763:A:AC | acceptor_gain | 1.0000 |
| 19:47531763:A:C | acceptor_gain | 1.0000 |
| 19:47532907:A:AC | donor_gain | 1.0000 |
| 19:47532908:C:CC | donor_gain | 1.0000 |
| 19:47532908:CGG:C | donor_gain | 1.0000 |
| 19:47539717:C:CA | donor_gain | 1.0000 |
| 19:47540191:C:A | donor_gain | 1.0000 |
| 19:47540336:C:CC | acceptor_gain | 1.0000 |
| 19:47540345:A:C | acceptor_gain | 1.0000 |
| 19:47549236:C:CA | donor_gain | 1.0000 |
| 19:47549243:A:AC | donor_gain | 1.0000 |
| 19:47549244:C:CC | donor_gain | 1.0000 |
| 19:47549262:AAAGG:A | donor_gain | 1.0000 |
| 19:47549294:T:TA | donor_gain | 1.0000 |
| 19:47549299:T:A | donor_gain | 1.0000 |
| 19:47555545:CTCA:C | donor_loss | 1.0000 |
| 19:47555546:TCA:T | donor_loss | 1.0000 |
| 19:47555547:CAC:C | donor_loss | 1.0000 |
| 19:47555549:C:CA | donor_loss | 1.0000 |
| 19:47521378:C:T | acceptor_gain | 0.9900 |
AlphaMissense
8777 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:47545973:G:C | H186D | 0.999 |
| 19:47549262:A:C | F177L | 0.999 |
| 19:47549262:A:T | F177L | 0.999 |
| 19:47549264:A:G | F177L | 0.999 |
| 19:47549285:A:G | C170R | 0.999 |
| 19:47549346:G:C | F149L | 0.999 |
| 19:47549346:G:T | F149L | 0.999 |
| 19:47549348:A:G | F149L | 0.999 |
| 19:47549369:A:G | C142R | 0.999 |
| 19:47545971:G:C | H186Q | 0.998 |
| 19:47545971:G:T | H186Q | 0.998 |
| 19:47549245:A:G | L183P | 0.998 |
| 19:47549261:T:C | K178E | 0.998 |
| 19:47549263:A:G | F177S | 0.998 |
| 19:47549274:G:C | C173W | 0.998 |
| 19:47549275:C:T | C173Y | 0.998 |
| 19:47549276:A:G | C173R | 0.998 |
| 19:47549307:G:C | H162Q | 0.998 |
| 19:47549307:G:T | H162Q | 0.998 |
| 19:47549319:G:C | H158Q | 0.998 |
| 19:47549319:G:T | H158Q | 0.998 |
| 19:47549358:G:C | C145W | 0.998 |
| 19:47549359:C:T | C145Y | 0.998 |
| 19:47549360:A:G | C145R | 0.998 |
| 19:47549367:G:C | C142W | 0.998 |
| 19:47521371:A:C | F1298L | 0.997 |
| 19:47521371:A:T | F1298L | 0.997 |
| 19:47521373:A:G | F1298L | 0.997 |
| 19:47545891:A:G | L213P | 0.997 |
| 19:47549259:C:A | K178N | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000016070 (19:47542841 A>G), RS1000097108 (19:47547629 G>C), RS1000200464 (19:47558358 G>T), RS1000258500 (19:47552077 C>T), RS1000275382 (19:47561346 G>A), RS1000355405 (19:47521914 G>A), RS1000394063 (19:47523730 A>G), RS1000439402 (19:47545744 G>A), RS1000459123 (19:47567011 G>A), RS1000463337 (19:47546053 C>T), RS1000739085 (19:47546911 G>A), RS1000742925 (19:47555387 G>A), RS1000768587 (19:47566012 A>G), RS1000795433 (19:47551069 G>T), RS1000806809 (19:47522621 C>T)
Disease associations
OMIM: gene MIM:619942 | disease phenotypes:
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| male infertility with azoospermia or oligozoospermia due to single gene mutation | Limited | Autosomal recessive |
Mondo (1): (MONDO:0018393)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008103_65 | Bipolar disorder | 7.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases mutagenesis, decreases expression, decreases methylation | 3 |
| perfluorooctanoic acid | increases expression | 2 |
| Cadmium Chloride | decreases expression, increases abundance | 2 |
| bisphenol A | decreases methylation | 1 |
| arsenite | increases methylation | 1 |
| bleomycetin | decreases expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Atrazine | increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Phenobarbital | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Triclosan | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Okadaic Acid | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.